Tonix Pharmaceuticals (TNXP) News Today $9.17 -0.50 (-5.17%) Closing price 04:00 PM EasternExtended Trading$9.34 +0.17 (+1.85%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated at StockNews.comFebruary 12, 2025 | americanbankingnews.comTonix stock gains on business update, preliminary earnings reportFebruary 8, 2025 | msn.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.7% - Here's WhyTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.7% - What's Next?February 7, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 13.2% - Should You Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 13.2% - Here's WhyFebruary 7, 2025 | marketbeat.comWhat's Going On With Tonix Pharmaceuticals Shares Friday?February 7, 2025 | benzinga.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Up - Should You Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Up - Still a Buy?February 7, 2025 | marketbeat.comTonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and ...February 7, 2025 | gurufocus.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Down - Here's WhyTonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Down - What's Next?February 7, 2025 | marketbeat.comTonix Pharmaceuticals Holding Corp. Reports $98.8 Million Cash Balance and Announces Debt-Free Status Ahead of FDA Decision on TNX-102 SLFebruary 7, 2025 | quiverquant.comTonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End CashFebruary 7, 2025 | globenewswire.comTonix reports positive results in TNX-1500 phase 1 trialFebruary 6, 2025 | msn.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 12.6% - Time to Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 12.6% - What's Next?February 6, 2025 | marketbeat.comTonix Pharmaceuticals Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoimmune DiseasesFebruary 6, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.7% - Time to Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.7% - Time to Sell?February 5, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Down - Here's What HappenedTonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Down - What's Next?February 5, 2025 | marketbeat.comTonix Pharmaceuticals trading halted, news pendingFebruary 5, 2025 | markets.businessinsider.comTonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor ConferenceFebruary 5, 2025 | investing.comTonix Pharmaceuticals to Participate in the 2025 BIO CEO & Investor ConferenceFebruary 5, 2025 | globenewswire.comTonix Pharmaceuticals appoints new CTO amid drug developmentFebruary 4, 2025 | msn.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Craters on Stock Split before FDA CallFebruary 4, 2025 | tipranks.comTonix Pharma Promotes Fogarty to Chief Technology OfficerFebruary 4, 2025 | tipranks.comTonix Pharmaceuticals Promotes Siobhan Fogarty to Chief Technical OfficerFebruary 4, 2025 | globenewswire.comTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock SplitFebruary 3, 2025 | finanznachrichten.deTonix Pharmaceuticals announces reverse stock splitFebruary 3, 2025 | msn.comTonix Pharmaceuticals Announces 1-for-100 Reverse Stock SplitFebruary 3, 2025 | gurufocus.comTonix Pharmaceuticals to conduct reverse stock splitFebruary 3, 2025 | seekingalpha.comTonix Pharmaceuticals Announces 1-for-100 Reverse Stock SplitFebruary 3, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading 11.5% Higher - Here's What HappenedTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 11.5% - What's Next?February 2, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated by Analysts at StockNews.comStockNews.com began coverage on shares of Tonix Pharmaceuticals in a research report on Sunday. They issued a "hold" rating on the stock.February 2, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 7.7% - Time to Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 7.7% - What's Next?February 1, 2025 | marketbeat.comTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 94.5% in JanuaryTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Get Free Report) was the target of a large increase in short interest during the month of January. As of January 15th, there was short interest totalling 7,780,000 shares, an increase of 94.5% from the December 31st total of 4,000,000 shares. Approximately 4.2% of the company's shares are sold short. Based on an average daily trading volume, of 100,730,000 shares, the days-to-cover ratio is currently 0.1 days.January 31, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 11.5% - What's Next?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 11.5% Higher - Time to Buy?January 31, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 6.7% - Time to Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 6.7% Higher - Here's WhyJanuary 31, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 21.8% - Here's What HappenedTonix Pharmaceuticals (NASDAQ:TNXP) Trading 21.8% Higher - Here's What HappenedJanuary 30, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 7.7% - Here's WhyTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 7.7% - Time to Sell?January 30, 2025 | marketbeat.comIs Tonix Pharmaceuticals the Next Biotech Breakout? Tonix Pharmaceuticals' innovative approach to fibromyalgia treatment positions the company for substantial market disruption and long-term growth.January 30, 2025 | marketbeat.com3 Penny Stocks to Watch Now, 1/30/25January 30, 2025 | tipranks.comShort Interest in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Rises By 94.5%Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Get Free Report) saw a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 7,780,000 shares, an increase of 94.5% from the December 31st total of 4,000,000 shares. Approximately 4.2% of the company's stock are sold short. Based on an average daily trading volume, of 100,730,000 shares, the short-interest ratio is presently 0.1 days.January 29, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 11.5% - Here's What HappenedTonix Pharmaceuticals (NASDAQ:TNXP) Trading 11.5% Higher - Time to Buy?January 29, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading 6.7% Higher - Here's What HappenedTonix Pharmaceuticals (NASDAQ:TNXP) Trading 6.7% Higher - Here's WhyJanuary 29, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 21.8% - What's Next?Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 21.8% - What's Next?January 28, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading 11.5% Higher - Time to Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 11.5% Higher - Time to Buy?January 27, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 22.4% - Should You Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 22.4% - Here's WhyJanuary 26, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 13.2% - Should You Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 13.2% - Here's WhyJanuary 25, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 7.6% - Should You Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 7.6% - What's Next?January 24, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 22.4% - Still a Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 22.4% - Should You Buy?January 24, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading 13.2% Higher - Here's WhyTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 13.2% - Time to Buy?January 23, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 7.6% - Should You Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 7.6% Higher - Still a Buy?January 22, 2025 | marketbeat.comTonix appoints Gary Ainsworth as VP, market accessJanuary 9, 2025 | markets.businessinsider.comTonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market AccessJanuary 8, 2025 | finance.yahoo.com Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address TNXP Media Mentions By Week TNXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNXP News Sentiment▼0.000.60▲Average Medical News Sentiment TNXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNXP Articles This Week▼03▲TNXP Articles Average Week Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Galectin Therapeutics News Inozyme Pharma News Acumen Pharmaceuticals News Entera Bio News X4 Pharmaceuticals News Cellectis News Scilex News Protara Therapeutics News IGM Biosciences News Aligos Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNXP) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNXP Stock Alerts